Stay updated on Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial
Sign up to get notified when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.

Latest updates to the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page
- Check6 days agoChange DetectedThe record history now displays new fields 'Last verified' and 'Last known status was', and the revision label updated to v3.6.0 (replacing v3.5.5).SummaryDifference3%

- Check13 days agoChange DetectedA new Revision: v3.5.5 entry is added to the history, superseding the previous Revision: v3.5.4. This reflects a site-wide update to the page rendering or tooling rather than a change to the study data.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision labeled v3.5.4 has been added to the page's history, replacing the previous v3.5.3 entry and updating the version shown in the footer.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page’s footer now shows a new ClinicalTrials.gov site revision (v3.5.3 rather than v3.5.2), reflecting an update to the platform version rather than changes to the clinical trial record itself.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry v3.5.2 was added to the history and the previous v3.5.0 entry was removed.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision history updated to include a new revision v3.5.0 and remove the older v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cadonilimab & Regorafenib Combo in Biliary Tumours Clinical Trial page.